Final Rule Paves Way for Drug Imports to Reduce Patient Costs

The Department of Health and Human Services and the Food and Drug Administration have issued a final rule and guidance that paves the way for states to allow pharmacists and wholesalers to import prescription drugs in order to reduce costs for patients. The final rule implements a provision of federal law that allows FDA-authorized programs to import [...]

By | 2020-10-27T16:07:59-07:00 October 27th, 2020|Uncategorized|0 Comments

Trump Issues Executive Orders to Reduce Drug Costs

President Trump has issued executive orders aimed at reducing the cost of medications by tying Medicare payment for outpatient drugs to international prices, passing drug-maker rebates to patients and not middlemen, and allowing individuals to import prescription medications. Another executive order aims to force community health centers that receive 340B drug discounts to pass discounts [...]

By | 2020-09-01T12:55:37-07:00 September 1st, 2020|Uncategorized|0 Comments

High-Deductible Plans Saddling Workers with Bigger Drug Outlays

A new study has found that high-deductible plans and increased use of coinsurance are exposing health plan enrollees to higher and higher pharmaceutical costs. One of the big problems for many enrollees in high-deductible plans is that their outlays for drugs may not count towards their health plan deductibles and, if they are enrolled in [...]

By | 2020-02-05T10:32:59-08:00 February 5th, 2020|Healthcare|0 Comments